Operating Activities: | |
Net income | 374.21M |
Adjustments to reconcile net income to net cash provided by operating activities: | |
Depreciation | 40.33M |
Amortization | 22.22M |
Loss (gain) on sale of property and equipment | 155K |
Provision for doubtful accounts | 2.56M |
Deferred income taxes | |
Unrealized foreign currency losses/(gains) | 19.54M |
Provision for obsolete and slow moving inventories | 20.94M |
Stock compensation expense | 29.21M |
Realized losses/(gains) on marketable securities | -1.07M |
Changes in operating assets and liabilities, net of acquisitions: | |
Accounts receivable | 76.37M |
Inventories | -41M |
Other current assets | |
Accounts payable | -40.69M |
Other current and non-current liabilities | 1.94M |
Deferred revenue | -13.66M |
Deferred cost | -9.91M |
Income taxes payable | 14.65M |
License fees | |
Net cash provided by operating activities | |
Investing activities: | |
Purchases of property and equipment | -42.16M |
Purchase of intangible assets | -4.71M |
Purchase of marketable securities | |
Redemption of marketable securities | |
Change in restricted cash | -6K |
Net cash (used in)/provided by investing activities | |
Financing activities: | |
Proceeds from issuance of common stock through stock purchase and stock option plans | |
Taxes paid related to net share settlement of equity awards | |
Stock repurchase | -65.22M |
Dividends | -289.33M |
Tax benefit related to stock option exercise | 365K |
Net cash provided by/(used in) financing activities | |
Effect of exchange rate changes on cash and cash equivalents | 7.22M |
Net increase in cash and cash equivalents | 79.49M |
Cash and cash equivalents at beginning of period | 833.07M |
Cash and cash equivalents at end of period | 912.56M |